Baird upgraded Amedisys (NASDAQ: AMED) from Underperform to Neutral with a price target of $25.00.

For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.

Shares of Amedisys closed at $21.76 yesterday.